H
E
A
L
T
H
C
A
R
E
AFRICA issionpharma Zambia has entered new territory over the past 18 months as it looks to change the dynamics of Zambia’s healthcare sector through a localisation and enrichment focus that is set to facilitate sustainability previously unseen in the country’s industry. Although technically present in Zambia for more than 20 years alongside Ngansa Pharmaceuticals before also operating as a subsidiary for Eurapharma from 2012 as well - it was 2015 that signified the modern day Missionpharma Zambia that is so reputed today. Unveiling his plan for truly localised prominence alongside Ngansa’s owner, Clement Andala, the Company’s General Manager, Jacob Thorup Cohn initiated a journey that is set to bring long-term stability and healthcare prevalence to a country eagerly awaiting such an approach. “At Missionpharma Zambia we combine the strengths of Ngansa’s insights into the B2B world in Zambia, and our group volume deliveries to the public Sector,” Cohn introduces. “Then we also introduce our hospital equipment division under the Missionpharma umbrella; making significant investments into local stock and local training, to both create jobs and to provide service possibilities for the hospitals, which they have not had before.” The business’ core function is to assure the Government and NGOs that the generic drugs they are acquiring are safe across the board; securing both production and importation facets in the process. “Poor generic drugs are not only dangerous for the individual patient, but also for societies as a whole,” Cohn adds. “And from our original quality assurance for individual items we have developed into being the largest manufacturer of medical kits in the world, basically utilising
WWW.AFRICAOUTLOOKMAG.COM
3